OnKure Therapeutics Class A Common Stock share price logo

OnKure Therapeutics Class A Common Stock

NASDAQ: OKUR

Small Cap

$4.35

+0.15

(+3.57%)

as on

OnKure Therapeutics Class A Common Stock Stock Performance

as on June 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.97
    $4.46
    downward going graph

    8.74%

    Downside

    2.53%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.91
    $5.38
    downward going graph

    56.09%

    Downside

    23.68%

    Upside

    downward going graph

OnKure Therapeutics Class A Common Stock share price movements today

Previous Close
$4.20
Open
$4.21
Volume
321.2K
Day's Low - High
$3.97 - $4.46
52 Week Low - High
$1.91 - $5.38

OnKure Therapeutics Class A Common Stock Historical Returns

1 Month Return
-0.24 %
3 Month Return
+ 5.53 %
1 Year Return
+ 64.06 %
3 Year Return
0 %
5 Year Return
0 %

OnKure Therapeutics Class A Common Stock Stock Fundamentals & Key Indicators

Check OnKure Therapeutics Class A Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$179.4M

EPS (TTM)

-2.5033

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-42.73%

OnKure Therapeutics Class A Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of OnKure Therapeutics Class A Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$179.4MNANA0.00%NA
BUY$38.2B65.93%71.9612.55%NA
BUY$118.5B144.05%27.735.51%NA
BUY$64.2B13.51%14.9529.65%0.59%

Stock Returns calculator for OnKure Therapeutics Class A Common Stock Stock including INR - Dollar returns

The OnKure Therapeutics Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

OnKure Therapeutics Class A Common Stock investment value today

Current value as on today

₹1,87,165

Returns

₹87,165

(+87.17%)

Returns from OnKure Therapeutics Class A Common Stock Stock

₹69,922 (+69.92%)

Dollar Impact

₹17,244 (+17.24%)

Indian Investors' Interest in OnKure Therapeutics Class A Common Stock Stock

Search interest for OnKure Therapeutics Class A Common Stock Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

OnKure Therapeutics Class A Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
21
-9
-14
-4
-33
-17
-16
-15
-14
-15
EBITDA
18
-9
-13
-3
-31
-15
-15
-14
-13
-14
Interest Expense
-
-
0
0
-
-
-
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
18
-9
-14
-3
-35
-15
-15
-14
-13
-15
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
18
-9
-14
-3
-35
-15
-15
-14
-13
-15
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

OnKure Therapeutics Class A Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
0
0
0
0
Operating Income
-29
-36
-54
-62
EBITDA
-29
-34
-51
-58
Interest Expense
-
-
0
0
Depreciation
0
0
0
0
Income Before Tax
-29
-35
-52
-59
Income Tax Expense
-
-
-
-
Net Income
-29
-35
-52
-59
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

OnKure Therapeutics Class A Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-9
-14
-11
-35
-15
-15
-14
-13
-15
Operating Cash Flow
-10
-6
-10
-21
-14
-13
-13
-11
-12
Investing Cash Flow
0
0
0
-45
0
0
0
0
0
Financing Cash Flow
0
5
0
114
0
-
-
0
145
Change in Cash
-10
0
-10
50
-14
-13
-13
-11
133

OnKure Therapeutics Class A Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-39
-29
-35
-52
-59
Operating Cash Flow
-37
-26
-34
-51
-51
Investing Cash Flow
-23
-1
0
15
0
Financing Cash Flow
132
26
53
116
0
Change in Cash
71
-1
18
80
-51

Global Institutional Holdings in OnKure Therapeutics Class A Common Stock

Funds
Holdings
Vanguard Capital Management, LLC
1.44%
CANTOR FITZGERALD, L. P.
0.24%
Sofinnova Ventures
0.35%
Highbridge Capital Management, LLC
1.32%
Vanguard Group Inc
1.55%

Insights on OnKure Therapeutics Class A Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, OKUR has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, OnKure Therapeutics, Inc. Class A Common Stock has experienced a drawdown of -94.0%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 73.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, OKUR stock has moved down by -94.0%

About OnKure Therapeutics Class A Common Stock

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
OrganisationOnKure Therapeutics Class A Common Stock
Headquarters6707 Winchester Circle, Boulder, CO, United States, 80301
IndustryBiotechnology
CEODr. Nicholas A. Saccomano Ph.D.
E-voting on sharesClick here to vote

Key Management of OnKure Therapeutics Class A Common Stock

Name

Title

Mr. Jason A. Leverone CPA

Chief Financial Officer

Dr. Isaac Manke Ph.D.

Senior VP of Business Development & Director

Dr. James Blake Ph.D.

Senior Vice President of Computational Drug Discovery

Dr. Kevin S. Litwiler Ph.D.

Senior Vice President of DMPK & Clinical Pharmacology

Ms. Roberta Alton

Senior Vice President of Clinical Operations

Dr. Nicholas A. Saccomano Ph.D.

President, CEO & Director

Dr. Samuel Agresta M.D., M.P.H.

Chief Medical Officer

Dr. Dylan Hartley Ph.D.

Chief Scientific Officer

Mr. Rogan P. Nunn J.D.

General Counsel & Secretary

Dr. Mark L. Boys Ph.D.

Senior Vice President of Discovery Chemistry

FAQs

What is OnKure Therapeutics Class A Common Stock share price today?

OnKure Therapeutics Class A Common Stock share price today is $4.35 as on at the close of the market. OnKure Therapeutics Class A Common Stock share today touched a day high of $4.46 and a low of $3.97.

What is the 52 week high and 52 week low for OnKure Therapeutics Class A Common Stock share?

OnKure Therapeutics Class A Common Stock share touched a 52 week high of $5.38 on and a 52 week low of $1.91 on . OnKure Therapeutics Class A Common Stock stock price today i.e. is closed at $4.35,which is 19.14% down from its 52 week high and 127.75% up from its 52 week low.

What is OnKure Therapeutics Class A Common Stock's market capitalisation today?

OnKure Therapeutics Class A Common Stock market capitalisation is $0.00T as on .

How to invest in OnKure Therapeutics Class A Common Stock Stock (OKUR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for OnKure Therapeutics Class A Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in OnKure Therapeutics Class A Common Stock Shares that will get you 0.3448 shares as per OnKure Therapeutics Class A Common Stock share price of $4.35 per share as on June 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy OnKure Therapeutics Class A Common Stock Stock (OKUR) from India?

Indian investors can start investing in OnKure Therapeutics Class A Common Stock (OKUR) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in OnKure Therapeutics Class A Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on OnKure Therapeutics Class A Common Stock share’s latest price of $4.35 as on June 25, 2026 at 1:29 am IST, you will get 2.2989 shares of OnKure Therapeutics Class A Common Stock. Learn more about fractional shares .